Clinical evaluation of 4-propylamino-1H-pyrazolo [3,4-d]pyrimidine (NSC-4928).
D000970:Antineoplastic Agents / Q000628:therapy*; D001393:Azoles / Q000628:therapy*; D006801:Humans; D011743:Pyrimidines / Q000628:therapy*
D000970:Antineoplastic Agents; D001393:Azoles; D011743:Pyrimidines; C030986:pyrimidine
ANTINEOPLASTIC AGENTS/therapy; AZOLES/therapy; PYRIMIDINES/therapy